Download PDF
Planta Med 2006; 72(14): 1305-1310
DOI: 10.1055/s-2006-951692
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Wogonin Inhibits IL-6-Induced Angiogenesis via Down-Regulation of VEGF and VEGFR-1, not VEGFR-2

Chiu-Mei Lin1 , 2 , Hang Chang3 , 4 , Yeh-Hsu Chen6 , I-Hsing Wu2 , Jen-Hwey Chiu1 , 5 , 7
  • 1Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
  • 2Department of Emergency Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, R.O.C.
  • 3Taipei City Hospital, Taipei, Taiwan, R.O.C.
  • 4College of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.
  • 5Division of General Surgery, Department of Surgery, Veterans General Hospital, Taipei, Taiwan, R.O.C.
  • 6Division of Infectious diseases, Department of Internal Medicine, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
  • 7Research Center for Traditional Chinese Medicine. Veterans General Hospital, Taipei, Taiwan, R.O.C.
Further Information

Publication History

Received: May 3, 2006

Accepted: August 21, 2006

Publication Date:
06 October 2006 (online)

    Permissions and Reprints

Abstract

So far, no antiangiogenic activity of wogonin, a flavonoid, on human umbilical vein endothelial cells (HUVECs) has been demonstrated. The aim of this study was to investigate the effects of wogonin on IL-6-induced angiogenesis in HUVEC cultures and chorioallantoic membrane (CAM) neovascularization. The in vivo CAM model was applied to evaluate the percentage of new vessel formations, followed by measurement of endothelial migration and tube formation in HUVEC cultures. The results revealed that wogonin (10-8∼10-5M) concentration-dependently inhibited IL-6-induced angiogenesis. The signaling pathway was through down-regulation of the autocrine loop of VEGF and VEGFR-1, but not of VEGFR-2. Furthermore, the regulating loop of the IL-6 receptor complex was also attenuated via expression of sIL-6Rα and gp130, but not of IL-6/IL-6R binding density. We conclude that wogonin is a suppressive agent of the autoregulated loop of VEGF, VEGFR-1 and the IL-6 receptor complex.

Key words

Wogonin - angiogenesis - IL-6 - IL-6R - VEGF - VEGFR-1

References

  • 1 Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M. et al . Cancer prevention by natural compounds.  . 2004;  19 245-63
    PubMedGoogle Scholar
  • 2 Kanadaswami C, Lee L T, Lee P P, Hwang J J, Ke F C, Huang Y T. et al . The antitumor activities of flavonoids.  . 2005;  19 895-909
    PubMedGoogle Scholar
  • 3 Lee , Kim Y O, Kim H, Kim S Y, Noh H S, Kang S S. et al . Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia.  FASEB J. 2003;  17 1943-4
    PubMedGoogle Scholar
  • 4 Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi.  Biochem Biophys Acta. 1999;  1472 643-50
    PubMedGoogle Scholar
  • 5 Chang Y L, Shen J J, Wung B S, Cheng J J, Wang D L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells.  Mol Pharmacol. 2001;  60 507-13
    PubMedGoogle Scholar
  • 6 Augustin H G. Antiangiogenic tumor therapies - will it work.  Trends Pharmacol Sci. 1998;  19 216-22
    CrossrefPubMedGoogle Scholar
  • 7 Feghali C A, Wright T M. Cytokines in acute and chronic inflammation.  Bioscience. 1997;  2 12-26
    PubMedGoogle Scholar
  • 8 Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction modeling.  Circ Res. 2004;  94 1543-53
    CrossrefPubMedGoogle Scholar
  • 9 Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay J Y. Prognostic value of serum levels of interleukin 6 and serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.  Br J Cancer. 2003;  88 1721-6
    CrossrefPubMedGoogle Scholar
  • 10 Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation.  Clin Sci (Lond). 2005;  108 205-13
    PubMedGoogle Scholar
  • 11 Aggarwal B B, Bhardwaj A, Aggarwal R S, Seeram N P, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.  Anticancer Res. 2004;  24 2783-840
    PubMedGoogle Scholar
  • 12 Jaffe E A, Nachman R L, Becker C G, Minick C R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.  J Clin Invest. 1973;  52 2745-56
    PubMedGoogle Scholar
  • 13 Hernandez-Rodriguez J, Sergarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban M J. et al . Elevated production of interleukin-6 as associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis.  Circulation. 2003;  107 2428-34
    CrossrefPubMedGoogle Scholar
  • 14 Lay I S, Chiu J H, Shiao M S, Lui W Y, Wu C W. Crude extract of Salvia mitiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line.  Planta Med. 2003;  69 26-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Nicosia R F, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro .  Lab Invest. 1990;  63 15-22
    PubMedGoogle Scholar
  • 16 Lin S K, Tsai S C, Lee C C, Wang B W, Liou J Y, Shyu K G. Berberine inhibits HIF-1 expression via enhanced proteolysis.  Mol Pharmacol. 2004;  66 612-9
    PubMedGoogle Scholar
  • 17 Taga T, Kishimoto T. Cytokine receptors and signal transduction.  FASEB J. 1992;  6 3387-96
    PubMedGoogle Scholar
  • 18 Yang S H, Lin J K, Huang C J, Chen W S, Li S Y, Chiu J H. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor upregulation.  J Surg Res. 2005;  128 140-6
    PubMedGoogle Scholar
  • 19 Nakamura N, Hayasaka S, Zhang X Y, Nagaki Y, Matsumoto M, Hayasaka Y. et al . Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappa b binding activities induced by interleukin-1 beta in human retinal pigment epithelial cell line.  Exp Eye Res. 2003;  77 195-202
    CrossrefPubMedGoogle Scholar
  • 20 Park B K, Heo M Y, Park H, Kim H P. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix.  Eur J Pharmacol. 2001;  425 153-7
    CrossrefPubMedGoogle Scholar
  • 21 Ravindranath M H, Muthugounder S, Presser N, Viswannthan S. Anticancer therapeutic potential of soy isoflavone, genistein.  Adv Exp Med Biol. 2004;  546 121-65
    PubMedGoogle Scholar
  • 22 Fang J, Xia C, Cao Z, Zheng J Z, Reed E, Jiang B H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.  FASEB J. 2005;  19 342-53
    CrossrefPubMedGoogle Scholar
  • 23 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease.  Nat Med. 1995;  1 27-31
    CrossrefPubMedGoogle Scholar
  • 24 Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.  Cardiovasc Res. 2001;  49 568-81
    CrossrefPubMedGoogle Scholar
  • 25 Jackson M W, Roberts J S, Heckford S E, Ricciardelli C, Stahl J, Horsfall D J. et al . A potential autocrine role for vascular endothelial growth factor in prostate cancer.  Cancer Res. 2002;  62 854-9
    PubMedGoogle Scholar
  • 26 Fong G H, Rossant J, Gertsenstein M, Breitman M L. Role of the Flt-1 receptor tyrosine kinase in regulation the assembly of vascular endothelium.  Nature. 1995;  376 66-70
    CrossrefPubMedGoogle Scholar
  • 27 Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis.  Am J Physiol Cell Physiol. 2001;  280 C1358-66
    CrossrefPubMedGoogle Scholar
  • 28 Heinrich P C, Behrmann I, Haan S, Hermanns H M, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6- type cytokine signaling and its regulation.  Biochem J. 2003;  374 1-20
    CrossrefPubMedGoogle Scholar
  • 29 Marin V, Montero-Julian F A, Gres S, Boulay V, Bongrand P, Farnarier C. et al . The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.  J Immunol. 2001;  167 3435-42
    PubMedGoogle Scholar
  • 30 Molostvov G, Morris A, Rose P, Basu S, Muller G. The effects of selective cytokines inhibiting drugs (CC-10 004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.  Br J Haematol. 2004;  124 366-75
    PubMedGoogle Scholar

Jen-Hwey Chiu

Institute of Traditional Medicine

School of Medicine

National Yang-Ming University

155, Sec. 2, Li-Nong St.

Peitou

Taipei 112

Taiwan

Republic of China

Phone: +886-2-2826-7178

Fax: +886-2-2822-5044

Email: chiujh@mailsrv.ym.edu.tw

      >